{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:23:49Z","timestamp":1792419829471,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with poor prognosis and rising incidence. Late detection and limited responsiveness to standard treatment translates into a 5-year overall survival of less than 12%. The pathology contributes to a desmoplastic tumor microenvironment that creates a physical barrier, leading to a dense, hypoxic environment that promotes further tumorigenesis, limited immunogenicity, and chemoresistance, resulting in a still significant translational gap in PDAC research. Feasible techniques to further elucidate tumorigenesis are indispensable because of the frequently limited predictive value of current preclinical models. PDAC organoids offer a powerful tool that can be rapidly generated from resected tumors and biopsies. This review summarizes the current technical and scientific knowledge and highlights the importance of the tumor microenvironment, the use of realistic oxygen conditions, and the role of the hypoxia-inducible factors. Additionally, various protocols based on different media and scaffolds are displayed, and it is illustrated how PDAC organoids can help to improve both diagnosis and treatment options. Finally, critical bottlenecks in modeling PDAC tumor-stromal interactions are identified, and integrated co-culture platforms are proposed as a promising solution for translational applications.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13046-026-03717-3","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:25:52Z","timestamp":1777620352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Progress and challenges in the development of advanced pancreatic cancer organoids"],"prefix":"10.1186","volume":"45","author":[{"given":"Katja","family":"Detert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Piotrowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Marongiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Leischner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich M.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Burkard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"1","key":"3717_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13014-019-1345-6","volume":"14","author":"M Orth","year":"2019","unstructured":"Orth M, Metzger P, Gerum S, Mayerle J, Schneider G, Belka C, et al. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiat Oncol. 2019;14(1):141. https:\/\/doi.org\/10.1186\/s13014-019-1345-6. PubMed PMID: 31395068 ; PubMed Central PMCID: PMC6688256.","journal-title":"Radiat Oncol"},{"issue":"8","key":"3717_CR2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: Advances and challenges. Cell. 2023;186(8):1729\u201354. https:\/\/doi.org\/10.1016\/j.cell. .2023.02.014 PubMed PMID: 37059070 ; PubMed Central PMCID: PMC10182830.","journal-title":"Cell"},{"issue":"11","key":"3717_CR3","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/nm.3973","volume":"21","author":"L Huang","year":"2015","unstructured":"Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med. 2015;21(11):1364\u201371. https:\/\/doi.org\/10.1038\/nm.3973. PubMed PMID: 26501191 ; PubMed Central PMCID: PMC4753163.","journal-title":"Nat Med"},{"issue":"9","key":"3717_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","volume":"8","author":"H Tiriac","year":"2018","unstructured":"Tiriac H, Belleau P, Engle DD, Plenker D, Desch\u00eanes A, Somerville TDD, et al. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov. 2018;8(9):1112\u201329. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0349. PubMed PMID: 29853643 ; PubMed Central PMCID: PMC6125219.","journal-title":"Cancer Discov"},{"issue":"6","key":"3717_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00535-023-01986-9","volume":"58","author":"T Sakakida","year":"2023","unstructured":"Sakakida T, Ishikawa T, Doi T, Morita R, Kataoka S, Miyake H, et al. Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan. J Gastroenterol. 2023;58(6):575\u201385. https:\/\/doi.org\/10.1007\/s00535-023-01986-9. PubMed PMID: 37029223 ; PubMed Central PMCID: PMC10199859.","journal-title":"J Gastroenterol"},{"issue":"2","key":"3717_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/CAD.0000000000000437","volume":"28","author":"HM Babiker","year":"2017","unstructured":"Babiker HM, Riaz IB, Shah SR, Von Hoff DD, Borad MJ. Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma. Anticancer Drugs. 2017;28(2):127\u201332. 10. 1097\/CAD.0000000000000437 PubMed PMID: 27685167 .","journal-title":"Anticancer Drugs"},{"issue":"10","key":"3717_CR7","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3390\/cancers12102750","volume":"12","author":"PO Frappart","year":"2020","unstructured":"Frappart PO, Hofmann TG. Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine. Cancers (Basel). 2020;12(10):2750. https:\/\/doi.org\/10.3390\/cancers12102750. PubMed PMID: 32987786 ; PubMed Central PMCID: PMC7598647.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"3717_CR8","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.3390\/cancers15112923","volume":"15","author":"L Mercanti","year":"2023","unstructured":"Mercanti L, Sindaco M, Mazzone M, Di Marcantonio MC, Piscione M, Muraro R, et al. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies. Cancers (Basel). 2023;15(11):2923. https:\/\/doi.org\/10.3390\/cancers15112923. PubMed PMID: 37296886 ; PubMed Central PMCID: PMC10251917.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"3717_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1615\/CritRevOncog.2019031417","volume":"24","author":"K Patel","year":"2019","unstructured":"Patel K, Siraj S, Smith C, Nair M, Vishwanatha JK, Basha R. Pancreatic Cancer: An Emphasis on Current Perspectives in Immunotherapy. Crit Rev Oncog. 2019;24(2):105\u201318. doi:10.1615\/CritRevOncog.2019031417 PubMed PMID: 31679206; PubMed Central PMCID: PMC8038975.","journal-title":"Crit Rev Oncog"},{"key":"3717_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.semcancer.2025.02.009","volume":"111","author":"K Murray","year":"2025","unstructured":"Murray K, Oldfield L, Stefanova I, Gentiluomo M, Aretini P, O\u2019Sullivan R, et al. Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer. Semin Cancer Biol. 2025;111:76\u201388. .009. PubMed PMID: 39986585 .","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3717_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s12885-018-4610-4","volume":"18","author":"AM Saad","year":"2018","unstructured":"Saad AM, Turk T, Al-Husseini MJ, Abdel-Rahman O. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer. 2018;18(1):688. https:\/\/doi.org\/10.1186\/s12885-018-4610-4. PubMed PMID: 29940910 ; PubMed Central PMCID: PMC6020186.","journal-title":"BMC Cancer"},{"issue":"4","key":"3717_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2011.12.042","volume":"142","author":"M Kanda","year":"2012","unstructured":"Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M, et al. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology. 2012;142(4):730\u2013e7339. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.042. PubMed PMID: 22226782 ; PubMed Central PMCID: PMC3321090.","journal-title":"Gastroenterology"},{"issue":"6","key":"3717_CR13","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-17-2994","volume":"24","author":"KL Aung","year":"2018","unstructured":"Aung KL, Fischer SE, Denroche RE, Jang GH, Dodd A, Creighton S, et al. Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res. 2018;24(6):1344\u201354. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2994. PubMed PMID: 29288237 ; PubMed Central PMCID: PMC5968824.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3717_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/PAT.0b013e32835f2205","volume":"45","author":"CL Cooper","year":"2013","unstructured":"Cooper CL, O\u2019Toole SA, Kench JG. Classification, morphology and molecular pathology of premalignant lesions of the pancreas. Pathology. 2013;45(3):286\u2013304. https:\/\/doi.org\/10.1097\/PAT.0b013e32835f2205.","journal-title":"Pathology"},{"issue":"8","key":"3717_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cels.2024.07.001","volume":"15","author":"ATF Bell","year":"2024","unstructured":"Bell ATF, Mitchell JT, Kiemen AL, Lyman M, Fujikura K, Lee JW, et al. PanIN and CAF Transitions in Pancreatic Carcinogenesis Revealed with Spatial Data Integration. Cell Syst. 2024;15(8):753\u2013e7695. https:\/\/doi.org\/10.1016\/j.cels.2024.07.001. PubMed PMID: 39116880 ; PubMed Central PMCID: PMC11409191.","journal-title":"Cell Syst"},{"issue":"12","key":"3717_CR16","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, et al. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol. 2015;39(12):1730\u201341. .0000000000000533 PubMed PMID: 26559377 ; PubMed Central PMCID: PMC4646710.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3717_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu, Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017;32(2):185\u2013e20313. https:\/\/doi.org\/10.1016\/j.ccell.2017.07.007. PubMed PMID: 28810144 ; PubMed Central PMCID: PMC5964983.","journal-title":"Cancer Cell"},{"issue":"8","key":"3717_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein AN, Brekken RA, Maitra A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020;17(8):487\u2013505. https:\/\/doi.org\/10.1038\/s41575-020-0300-1. PubMed PMID: 32393771 ; PubMed Central PMCID: PMC8284850.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11 Suppl","key":"3717_CR19","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.cgh.2009.07.039","volume":"7","author":"S Pandol","year":"2009","unstructured":"Pandol S, Edderkaoui M, Gukovsky I, Lugea A, Gukovskaya A. Desmoplasia of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol. 2009;7(11 Suppl):S44\u201347. https:\/\/doi.org\/10.1016\/j.cgh.2009.07.039. PubMed PMID: 19896098 ; PubMed Central PMCID: PMC4573641.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3717_CR20","doi-asserted-by":"publisher","first-page":"1287459","DOI":"10.3389\/fimmu.2024.1287459","volume":"15","author":"C Hartupee","year":"2024","unstructured":"Hartupee C, Nagalo BM, Chabu CY, Tesfay MZ, Coleman-Barnett J, West JT, et al. Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target. Front Immunol. 2024;15:1287459. https:\/\/doi.org\/10.3389\/fimmu.2024.1287459. PubMed PMID: 38361931 ; PubMed Central PMCID: PMC10867137.","journal-title":"Front Immunol"},{"key":"3717_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2020","volume":"484","author":"A Yamasaki","year":"2020","unstructured":"Yamasaki A, Yanai K, Onishi H. Hypoxia and pancreatic ductal adenocarcinoma. Cancer Lett. 2020;484:9\u201315. https:\/\/doi.org\/10.1016\/j.canlet.2020. 04.018 PubMed PMID: 32380129 .","journal-title":"Cancer Lett"},{"issue":"5","key":"3717_CR22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1053\/j.gastro.2023.12.018","volume":"166","author":"S Parte","year":"2024","unstructured":"Parte S, Kaur AB, Nimmakayala RK, Ogunleye AO, Chirravuri R, Vengoji R, et al. Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5\/ITGA4 Axis. Gastroenterology. 2024;166(5):842\u2013e8585. https:\/\/doi.org\/10.1053\/j.gastro.2023.12.018. PubMed PMID: 38154529 ; PubMed Central PMCID: PMC11694316.","journal-title":"Gastroenterology"},{"issue":"6","key":"3717_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.trecan","volume":"4","author":"AH Morrison","year":"2018","unstructured":"Morrison AH, Byrne KT, Vonderheide RH. Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer. 2018;4(6):418\u201328. https:\/\/doi.org\/10.1016\/j.trecan. .2018.04.001 PubMed PMID: 29860986 ; PubMed Central PMCID: PMC6028935.","journal-title":"Trends Cancer"},{"key":"3717_CR24","doi-asserted-by":"publisher","first-page":"107890","DOI":"10.1016\/j.intimp.2021.107890","volume":"98","author":"ZG Chen","year":"2021","unstructured":"Chen ZG, Wang Y, Fong WP, Hu MT, Liang JY, Wang L, et al. A quantitative score of immune cell infiltration predicts the prognosis in pancreatic ductal adenocarcinoma. Int Immunopharmacol. 2021;98:107890. https:\/\/doi.org\/10.1016\/j.intimp.2021.107890. PubMed PMID: 34174701 .","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3717_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13046-022-02519-7","volume":"41","author":"S Schuth","year":"2022","unstructured":"Schuth S, Le Blanc S, Krieger TG, Jabs J, Schenk M, Giese NA, et al. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system. J Exp Clin Cancer Res. 2022;41(1):312. https:\/\/doi.org\/10.1186\/s13046-022-02519-7. PubMed PMID: 36273171 ; PubMed Central PMCID: PMC9588250.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"3717_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","volume":"17","author":"C Nevala-Plagemann","year":"2020","unstructured":"Nevala-Plagemann C, Hidalgo M, Garrido-Laguna I. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer. Nat Rev Clin Oncol. 2020;17(2):108\u201323. https:\/\/doi.org\/10.1038\/s41571-019-0281-6. PubMed PMID: 31705130 .","journal-title":"Nat Rev Clin Oncol"},{"key":"3717_CR27","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.2147\/IJN.S413496","volume":"18","author":"H Duan","year":"2023","unstructured":"Duan H, Li L, He S. Advances and Prospects in the Treatment of Pancreatic Cancer. Int J Nanomed. 2023;18:3973\u201388. doi:10.2147\/IJN.S413496 PubMed PMID: 37489138; PubMed Central PMCID: PMC10363367.","journal-title":"Int J Nanomed"},{"key":"3717_CR28","doi-asserted-by":"publisher","unstructured":"Mahadevan KK, McAndrews KM, LeBleu VS, Yang S, Lyu H, Li B et al. Oncogenic Kras G12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8\u2009+\u2009T cells dependent manner. bioRxiv. 2023;2023.02.15.528757. https:\/\/doi.org\/10.1101\/2023.02.15.528757 PubMed PMID: 36824971 ; PubMed Central PMCID: PMC9948969.","DOI":"10.1101\/2023.02"},{"issue":"1","key":"3717_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","volume":"13","author":"Y Qian","year":"2020","unstructured":"Qian Y, Gong Y, Fan Z, Luo G, Huang Q, Deng S, et al. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. J Hematol Oncol. 2020;13(1):130. https:\/\/doi.org\/10.1186\/s13045-020-00958-3. PubMed PMID: 33008426 ; PubMed Central PMCID: PMC7532113.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"3717_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer \u2014 clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17(9):527\u201340. https:\/\/doi.org\/10.1038\/s41571-020-0363-5. PubMed PMID: 32398706 ; PubMed Central PMCID: PMC7442729.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"3717_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","volume":"52","author":"M Chan-Seng-Yue","year":"2020","unstructured":"Chan-Seng-Yue M, Kim JC, Wilson GW, Ng K, Figueroa EF, O\u2019Kane GM, et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat Genet. 2020;52(2):231\u201340. https:\/\/doi.org\/10.1038\/s41588-019-0566-9. PubMed PMID: 31932696 .","journal-title":"Nat Genet"},{"key":"3717_CR32","doi-asserted-by":"publisher","first-page":"886153","DOI":"10.3389\/fcell","volume":"10","author":"J Casamitjana","year":"2022","unstructured":"Casamitjana J, Espinet E, Rovira M. Pancreatic Organoids for Regenerative Medicine and Cancer Research. Front Cell Dev Biol. 2022;10:886153. https:\/\/doi.org\/10.3389\/fcell. 2022.886153 PubMed PMID: 35592251 ; PubMed Central PMCID: PMC9110799.","journal-title":"Front Cell Dev Biol"},{"key":"3717_CR33","doi-asserted-by":"publisher","unstructured":"Sr M. Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol. 2014;87(1035). https:\/\/doi.org\/10.1259\/bjr.20130676. PubMed PMID: 24588669 .","DOI":"10.1259\/bjr.20130676"},{"issue":"7","key":"3717_CR34","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1158\/1535-7163.MCT-09-0768","volume":"9","author":"DL Schwartz","year":"2010","unstructured":"Schwartz DL, Bankson JA, Lemos R, Lai SY, Thittai AK, He Y, et al. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. Mol Cancer Ther. 2010;9(7):2057\u201367. https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0768. PubMed PMID: 20587661 ; PubMed Central PMCID: PMC2935253.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3717_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41420-023-01334-z","volume":"9","author":"M Geyer","year":"2023","unstructured":"Geyer M, Schreyer D, Gaul LM, Pfeffer S, Pilarsky C, Queiroz K. A microfluidic-based PDAC organoid system reveals the impact of hypoxia in response to treatment. Cell Death Discov. 2023;9(1):20. https:\/\/doi.org\/10.1038\/s41420-023-01334-z. PubMed PMID: 36681673 ; PubMed Central PMCID: PMC9867742.","journal-title":"Cell Death Discov"},{"issue":"7","key":"3717_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/17460441.2019.1613370","volume":"14","author":"N Albadari","year":"2019","unstructured":"Albadari N, Deng S, Li W. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert Opin Drug Discov. 2019;14(7):667\u201382. https:\/\/doi.org\/10.1080\/17460441.2019.1613370. PubMed PMID: 31070059 ; PubMed Central PMCID: PMC6559821.","journal-title":"Expert Opin Drug Discov"},{"issue":"5","key":"3717_CR37","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/cas.13990","volume":"110","author":"Y Hayashi","year":"2019","unstructured":"Hayashi Y, Yokota A, Harada H, Huang G. Hypoxia\/pseudohypoxia-mediated activation of hypoxia-inducible factor-1\u03b1 in cancer. Cancer Sci. 2019;110(5):1510\u20137. https:\/\/doi.org\/10.1111\/cas.13990. PubMed PMID: 30844107 ; PubMed Central PMCID: PMC6501028.","journal-title":"Cancer Sci"},{"issue":"4","key":"3717_CR38","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s0360-3016","volume":"48","author":"AC Koong","year":"2000","unstructured":"Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, et al. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys. 2000;48(4):919\u201322. https:\/\/doi.org\/10.1016\/s0360-3016. (00)00803-8 PubMed PMID: 11072146 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3717_CR39","unstructured":"Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 2000;60(17):4693\u20136. PMID: 10987269."},{"issue":"6","key":"3717_CR40","first-page":"1661","volume":"7","author":"P Birner","year":"2001","unstructured":"Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res. 2001;7(6):1661\u20138. PubMed PMID: 11410504 .","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3717_CR41","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1152\/physrev.00030","volume":"92","author":"NR Prabhakar","year":"2012","unstructured":"Prabhakar NR, Semenza GL. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev. 2012;92(3):967\u20131003. https:\/\/doi.org\/10.1152\/physrev.00030. .2011 PubMed PMID: 22811423 ; PubMed Central PMCID: PMC3893888.","journal-title":"Physiol Rev"},{"key":"3717_CR42","doi-asserted-by":"publisher","unstructured":"Chee NT, Lohse I, Brothers SP. mRNA-to-protein translation in hypoxia. Mol Cancer. 2019;18(1):49. https:\/\/doi.org\/10.1186\/s12943-019-0968-4. PubMed PMID: 30925920; PubMed Central PMCID: PMC6441220.","DOI":"10.1186\/s12943-019-0968-4"},{"issue":"6","key":"3717_CR43","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1128\/MCB.01514-06","volume":"27","author":"Q Yan","year":"2007","unstructured":"Yan Q, Bartz S, Mao M, Li L, Kaelin WG. The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo. Mol Cell Biol. 2007;27(6):2092\u2013102. https:\/\/doi.org\/10.1128\/MCB.01514-06. PubMed PMID: 17220275 ; PubMed Central PMCID: PMC1820491.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"3717_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-023-00848-6","volume":"23","author":"X Yuan","year":"2024","unstructured":"Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig HK. Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nat Rev Drug Discov. 2024;23(3):175\u2013200. https:\/\/doi.org\/10.1038\/s41573-023-00848-6. PubMed PMID: 38123660 .","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3717_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00018-024-05537-0","volume":"82","author":"Y Shi","year":"2025","unstructured":"Shi Y, Gilkes DM. HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects. Cell Mol Life Sci. 2025;82(1):44. https:\/\/doi.org\/10.1007\/s00018-024-05537-0. PubMed PMID: 39825916 ; PubMed Central PMCID: PMC11741981.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3717_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molcel.2007.02.024","volume":"26","author":"F Li","year":"2007","unstructured":"Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, et al. Regulation of HIF-1\u03b1 Stability through S-nitrosylation. Mol Cell. 2007;26(1):63\u201374. https:\/\/doi.org\/10.1016\/j.molcel.2007.02.024. PubMed PMID: 17434127 ; PubMed Central PMCID: PMC2905600.","journal-title":"Mol Cell"},{"key":"3717_CR47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pharmthera.2016.04","volume":"164","author":"C Wigerup","year":"2016","unstructured":"Wigerup C, P\u00e5hlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther. 2016;164:152\u201369. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.04. .009 PubMed PMID: 27139518 .","journal-title":"Pharmacol Ther"},{"key":"3717_CR48","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/srep02799","volume":"3","author":"SJ Welsh","year":"2013","unstructured":"Welsh SJ, Dale AG, Lombardo CM, Valentine H, de la Fuente M, Schatzlein A, et al. Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule. Sci Rep. 2013;3:2799. https:\/\/doi.org\/10.1038\/srep02799. PubMed PMID: 24165797 ; PubMed Central PMCID: PMC3810677.","journal-title":"Sci Rep"},{"issue":"3","key":"3717_CR49","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cell.2007.08.045","volume":"131","author":"J Cheng","year":"2007","unstructured":"Cheng J, Kang X, Zhang S, Yeh ETH. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell. 2007;131(3):584\u201395. https:\/\/doi.org\/10.1016\/j.cell.2007.08.045. PubMed PMID: 17981124 ; PubMed Central PMCID: PMC2128732.","journal-title":"Cell"},{"issue":"32","key":"3717_CR50","doi-asserted-by":"publisher","first-page":"E3325","DOI":"10.1073\/pnas.1412840111","volume":"111","author":"ME Hubbi","year":"2014","unstructured":"Hubbi ME, Gilkes DM, Hu H, Kshitiz null, Ahmed I, Semenza GL. Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1\u03b1 to promote cell-cycle progression. Proc Natl Acad Sci U S A. 2014;111(32):E3325\u20133334. https:\/\/doi.org\/10.1073\/pnas.1412840111. PubMed PMID: 25071185 ; PubMed Central PMCID: PMC4136593.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3717_CR51","doi-asserted-by":"publisher","first-page":"e23551","DOI":"10.1002\/jbt.23551","volume":"38","author":"M Zhang","year":"2024","unstructured":"Zhang M, Wang Z, Wu Y, Chen M, Li J, Liu G. Hypoxia-induced factor-1\u03b1 promotes radioresistance of esophageal cancer cells by transcriptionally activating LINC01116 and suppressing miR-3612 under hypoxia. J Biochem Mol Toxicol. 2024;38(1):e23551. https:\/\/doi.org\/10.1002\/jbt.23551. PubMed PMID: 37983895 .","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"3717_CR52","doi-asserted-by":"publisher","first-page":"201049","DOI":"10.1016\/j.omton.2025.201049","volume":"33","author":"K Gronkowska","year":"2025","unstructured":"Gronkowska K, Ko\u0142acz-Milewska K, Michlewska S, P\u0142oszaj T, Borowiec M, Robaszkiewicz A. HIF1A, BRG1, and p300 interaction confers paclitaxel-induced drug resistance by enabling the overexpression of ABCC genes. Mol Ther Oncol. 2025;33(4):201049. https:\/\/doi.org\/10.1016\/j.omton.2025.201049. PubMed PMID: 41050430 ; PubMed Central PMCID: PMC12493206.","journal-title":"Mol Ther Oncol"},{"key":"3717_CR53","doi-asserted-by":"publisher","unstructured":"Doctor A, Laube M, Meister S, Kiss OC, Kopka K, Hauser S et al. Combined PET Radiotracer Approach Reveals Insights into Stromal Cell-Induced Metabolic Changes in Pancreatic Cancer In Vitro and In Vivo. Cancers (Basel). 2024;16(19):3393. https:\/\/doi.org\/10.3390\/cancers16193393. PubMed PMID: 39410013 ; PubMed Central PMCID: PMC11475921.","DOI":"10.3390\/cancers16193393"},{"issue":"1","key":"3717_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cancers13010089","volume":"13","author":"P Mayer","year":"2020","unstructured":"Mayer P, Kraft A, Witzel HR, Marnet N, H\u00f6rner N, Roth W, et al. Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging in Pancreatic Cancer is Associated with Tumor Hypoxia. Cancers (Basel). 2020;13(1):89. https:\/\/doi.org\/10.3390\/cancers13010089. PubMed PMID: 33396818 ; PubMed Central PMCID: PMC7801953.","journal-title":"Cancers (Basel)"},{"key":"3717_CR55","doi-asserted-by":"publisher","first-page":"1061388","DOI":"10.3389\/fimmu","volume":"13","author":"J Yuan","year":"2022","unstructured":"Yuan J, Li X, Yu S. Cancer organoid co-culture model system: Novel approach to guide precision medicine. Front Immunol. 2022;13:1061388. https:\/\/doi.org\/10.3389\/fimmu. 2022.1061388 PubMed PMID: 36713421 ; PubMed Central PMCID: PMC9877297.","journal-title":"Front Immunol"},{"issue":"2","key":"3717_CR56","doi-asserted-by":"publisher","first-page":"114418","DOI":"10.1016\/j.isci.2025.114418","volume":"29","author":"IV Hensel","year":"2025","unstructured":"Hensel IV, \u00c9li\u00e1s S, Steinhauer M, G\u00fcnther C, Resnik-Docampo M. Advanced human organoid-on-chip with physiological cellular complexity reveals bidirectional secretion patterns. iScience. 2025;29(2):114418. https:\/\/doi.org\/10.1016\/j.isci.2025.114418. PubMed PMID: 41585485 ; PubMed Central PMCID: PMC12829128.","journal-title":"iScience"},{"issue":"6","key":"3717_CR57","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41596-024-01093-w","volume":"20","author":"A Atamian","year":"2025","unstructured":"Atamian A, Birtele M, Hosseini N, Quadrato G. Generation and long-term culture of human cerebellar organoids from pluripotent stem cells. Nat Protoc. 2025;20(6):1584\u2013615. https:\/\/doi.org\/10.1038\/s41596-024-01093-w.","journal-title":"Nat Protoc"},{"issue":"1","key":"3717_CR58","doi-asserted-by":"publisher","first-page":"C151","DOI":"10.1152\/ajpcell.00120","volume":"319","author":"C Corr\u00f2","year":"2020","unstructured":"Corr\u00f2 C, Novellasdemunt L, Li VSW. A brief history of organoids. Am J Physiol Cell Physiol. 2020;319(1):C151\u201365. https:\/\/doi.org\/10.1152\/ajpcell.00120. .2020 PubMed PMID: 32459504 ; PubMed Central PMCID: PMC7468890.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"3717_CR59","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/SLA.0000000000005558","volume":"276","author":"L Demyan","year":"2022","unstructured":"Demyan L, Habowski AN, Plenker D, King DA, Standring OJ, Tsang C, et al. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy. Ann Surg. 2022;276(3):450\u201362. https:\/\/doi.org\/10.1097\/SLA.0000000000005558. PubMed PMID: 35972511 ; PubMed Central PMCID: PMC10202108.","journal-title":"Ann Surg"},{"issue":"20","key":"3717_CR60","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1038\/emboj.2013.204","volume":"32","author":"M Huch","year":"2013","unstructured":"Huch M, Bonfanti P, Boj SF, Sato T, Loomans CJM, van de Wetering M, et al. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5\/R-spondin axis. EMBO J. 2013;32(20):2708\u201321. https:\/\/doi.org\/10.1038\/emboj.2013.204. PubMed PMID: 24045232 ; PubMed Central PMCID: PMC3801438.","journal-title":"EMBO J"},{"issue":"4","key":"3717_CR61","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.3390\/ijms24044027","volume":"24","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li N, Zhu Y, Pancreatic Organoids. A Frontier Method for Investigating Pancreatic-Related Diseases. Int J Mol Sci. 2023;24(4):4027. https:\/\/doi.org\/10.3390\/ijms24044027. PubMed PMID: 36835437 ; PubMed Central PMCID: PMC9959977.","journal-title":"Int J Mol Sci"},{"key":"3717_CR62","doi-asserted-by":"publisher","first-page":"14686","DOI":"10.1038\/ncomms14686","volume":"8","author":"J Lee","year":"2017","unstructured":"Lee J, Snyder ER, Liu Y, Gu X, Wang J, Flowers BM, et al. Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells. Nat Commun. 2017;8:14686. https:\/\/doi.org\/10.1038\/ncomms14686. PubMed PMID: 28272465 ; PubMed Central PMCID: PMC5344977.","journal-title":"Nat Commun"},{"issue":"3","key":"3717_CR63","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.stem","volume":"22","author":"T Seino","year":"2018","unstructured":"Seino T, Kawasaki S, Shimokawa M, Tamagawa H, Toshimitsu K, Fujii M, et al. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression. Cell Stem Cell. 2018;22(3):454\u2013e4676. https:\/\/doi.org\/10.1016\/j.stem. .2017.12.009 PubMed PMID: 29337182 .","journal-title":"Cell Stem Cell"},{"key":"3717_CR64","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.canlet.2020.10.012","volume":"498","author":"JI Choi","year":"2021","unstructured":"Choi JI, Jang SI, Hong J, Kim CH, Kwon SS, Park JS, et al. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells. Cancer Lett. 2021;498:42\u201353. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.012. PubMed PMID: 33188841 .","journal-title":"Cancer Lett"},{"issue":"1\u20132","key":"3717_CR65","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio IIC, Engle DD, Corbo V, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160(1\u20132):324\u201338. https:\/\/doi.org\/10.1016\/j.cell.2014.12.021. PubMed PMID: 25557080 ; PubMed Central PMCID: PMC4334572.","journal-title":"Cell"},{"issue":"25","key":"3717_CR66","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","volume":"184","author":"S Raghavan","year":"2021","unstructured":"Raghavan S, Winter PS, Navia AW, Williams HL, DenAdel A, Lowder KE, et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell. 2021;184(25):6119\u2013e613726. https:\/\/doi.org\/10.1016\/j.cell.2021.11.017. PubMed PMID: 34890551 ; PubMed Central PMCID: PMC8822455.","journal-title":"Cell"},{"issue":"3","key":"3717_CR67","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.stemcr.2018.02.005","volume":"10","author":"CJM Loomans","year":"2018","unstructured":"Loomans CJM, Williams Giuliani N, Balak J, Ringnalda F, van Gurp L, Huch M, et al. Expansion of Adult Human Pancreatic Tissue Yields Organoids Harboring Progenitor Cells with Endocrine Differentiation Potential. Stem Cell Rep. 2018;10(3):712\u201324. https:\/\/doi.org\/10.1016\/j.stemcr.2018.02.005. PubMed PMID: 29539434 ; PubMed Central PMCID: PMC5918840.","journal-title":"Stem Cell Rep"},{"issue":"3","key":"3717_CR68","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14712\/fb2019065030109","volume":"65","author":"T Koblas","year":"2019","unstructured":"Koblas T, Leontovyc I, Loukotov\u00e1 S, Saudek F. Reprogramming of Human Pancreatic Organoid Cells into Insulin-Producing \u03b2-Like Cells by Small Molecules and in Vitro Transcribed Modified mRNA Encoding Neurogenin 3 Transcription Factor. Folia Biol (Praha). 2019;65(3):109\u201323. https:\/\/doi.org\/10.14712\/fb2019065030109. PubMed PMID: 31638558 .","journal-title":"Folia Biol (Praha)"},{"issue":"4","key":"3717_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.gendis.2018.09","volume":"5","author":"Y Pan","year":"2018","unstructured":"Pan Y, Zhao S, Cao Z. Organoid models of gastrointestinal Neoplasms: Origin, current status and future applications in personalized medicine. Genes Dis. 2018;5(4):323\u201330. https:\/\/doi.org\/10.1016\/j.gendis.2018.09. .002 PubMed PMID: 30591933 ; PubMed Central PMCID: PMC6303680.","journal-title":"Genes Dis"},{"key":"3717_CR70","doi-asserted-by":"publisher","first-page":"1327772","DOI":"10.3389\/fcell.2024.1327772","volume":"12","author":"K Kumano","year":"2024","unstructured":"Kumano K, Nakahashi H, Louphrasitthiphol P, Kuroda Y, Miyazaki Y, Shimomura O, et al. Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer. Front Cell Dev Biol. 2024;12:1327772. https:\/\/doi.org\/10.3389\/fcell.2024.1327772. PubMed PMID: 38374892 ; PubMed Central PMCID: PMC10875002.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"3717_CR71","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.stem.2016","volume":"18","author":"NF Shroyer","year":"2016","unstructured":"Shroyer NF. Tumor Organoids Fill the Niche. Cell Stem Cell. 2016;18(6):686\u20137. https:\/\/doi.org\/10.1016\/j.stem.2016. 05.020 PubMed PMID: 27257754 .","journal-title":"Cell Stem Cell"},{"issue":"9","key":"3717_CR72","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/pmic.200900758","volume":"10","author":"CS Hughes","year":"2010","unstructured":"Hughes CS, Postovit LM, Lajoie GA. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics. 2010;10(9):1886\u201390. https:\/\/doi.org\/10.1002\/pmic.200900758. PubMed PMID: 20162561 .","journal-title":"Proteomics"},{"key":"3717_CR73","doi-asserted-by":"publisher","unstructured":"Kozlowski MT, Crook CJ, Ku HT. Towards organoid culture without Matrigel. Commun Biol. 2021;4(1):1387. https:\/\/doi.org\/10.1038\/s42003-021-02910-8. PubMed PMID: 34893703; PubMed Central PMCID: PMC8664924.","DOI":"10.1038\/s42003-021-02910-8"},{"issue":"1","key":"3717_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41563-021-01085-1","volume":"21","author":"CR Below","year":"2022","unstructured":"Below CR, Kelly J, Brown A, Humphries JD, Hutton C, Xu J, et al. A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids. Nat Mater. 2022;21(1):110\u20139. https:\/\/doi.org\/10.1038\/s41563-021-01085-1. PubMed PMID: 34518665 ; PubMed Central PMCID: PMC7612137.","journal-title":"Nat Mater"},{"issue":"1","key":"3717_CR75","doi-asserted-by":"publisher","first-page":"10452","DOI":"10.1038\/s41598-018-28857-1","volume":"8","author":"SD Sackett","year":"2018","unstructured":"Sackett SD, Tremmel DM, Ma F, Feeney AK, Maguire RM, Brown ME, et al. Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas. Sci Rep. 2018;8(1):10452. https:\/\/doi.org\/10.1038\/s41598-018-28857-1. PubMed PMID: 29993013 ; PubMed Central PMCID: PMC6041318.","journal-title":"Sci Rep"},{"issue":"1","key":"3717_CR76","doi-asserted-by":"publisher","first-page":"a004903","DOI":"10.1101\/cshperspect.a004903","volume":"4","author":"RO Hynes","year":"2012","unstructured":"Hynes RO, Naba A. Overview of the matrisome\u2013an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol. 2012;4(1):a004903. https:\/\/doi.org\/10.1101\/cshperspect.a004903. PubMed PMID: 21937732 ; PubMed Central PMCID: PMC3249625.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"3717_CR77","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2533\/chimia.2017.342","volume":"71","author":"KS Hof","year":"2017","unstructured":"Hof KS, Bastings MMC. Programmable Control in Extracellular Matrix-mimicking Polymer Hydrogels. Chimia (Aarau). 2017;71(6):342\u20138. https:\/\/doi.org\/10.2533\/chimia.2017.342. PubMed PMID: 28662736 .","journal-title":"Chimia (Aarau)"},{"issue":"16","key":"3717_CR78","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1016\/j.biomaterials","volume":"26","author":"H Vihola","year":"2005","unstructured":"Vihola H, Laukkanen A, Valtola L, Tenhu H, Hirvonen J. Cytotoxicity of thermosensitive polymers poly(N-isopropylacrylamide), poly(N-vinylcaprolactam) and amphiphilically modified poly(N-vinylcaprolactam). Biomaterials. 2005;26(16):3055\u201364. https:\/\/doi.org\/10.1016\/j.biomaterials. .2004.09.008 PubMed PMID: 15603800 .","journal-title":"Biomaterials"},{"issue":"22","key":"3717_CR79","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1016\/j.devcel.2025.06","volume":"60","author":"A Chrisnandy","year":"2025","unstructured":"Chrisnandy A, Lutolf MP. An extracellular matrix niche secreted by epithelial cells drives intestinal organoid formation. Dev Cell. 2025;60(22):3116\u2013e31308. https:\/\/doi.org\/10.1016\/j.devcel.2025.06. .026 PubMed PMID: 40680738 .","journal-title":"Dev Cell"},{"key":"3717_CR80","doi-asserted-by":"publisher","first-page":"121647","DOI":"10.1016\/j.biomaterials.2022.121647","volume":"288","author":"W Zhang","year":"2022","unstructured":"Zhang W, Wauthier E, Lanzoni G, Hani H, Yi X, Overi D, et al. Patch Grafting of Organoids of Stem\/progenitors into Solid Organs Can Correct Genetic-Based Disease States. Biomaterials. 2022;288:121647. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121647. PubMed PMID: 36030102 ; PubMed Central PMCID: PMC10495116.","journal-title":"Biomaterials"},{"issue":"1","key":"3717_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1900\/RDS.2014.11.35","volume":"11","author":"L Jin","year":"2014","unstructured":"Jin L, Feng T, Chai J, Ghazalli N, Gao D, Zerda R, et al. Colony-forming progenitor cells in the postnatal mouse liver and pancreas give rise to morphologically distinct insulin-expressing colonies in 3D cultures. Rev Diabet Stud. 2014;11(1):35\u201350. .35 PubMed PMID: 25148366 ; PubMed Central PMCID: PMC4295799.","journal-title":"Rev Diabet Stud"},{"issue":"2","key":"3717_CR82","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1021\/nn204530r","volume":"6","author":"JS Rudra","year":"2012","unstructured":"Rudra JS, Sun T, Bird KC, Daniels MD, Gasiorowski JZ, Chong AS, et al. Modulating adaptive immune responses to peptide self-assemblies. ACS Nano. 2012;6(2):1557\u201364. https:\/\/doi.org\/10.1021\/nn204530r. PubMed PMID: 22273009 ; PubMed Central PMCID: PMC3289747.","journal-title":"ACS Nano"},{"issue":"12","key":"3717_CR83","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/cac2","volume":"41","author":"J Qu","year":"2021","unstructured":"Qu J, Kalyani FS, Liu L, Cheng T, Chen L. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy. Cancer Commun (Lond). 2021;41(12):1331\u201353. https:\/\/doi.org\/10.1002\/cac2. 12224 PubMed PMID: 34713636 ; PubMed Central PMCID: PMC8696219.","journal-title":"Cancer Commun (Lond)"},{"issue":"5986","key":"3717_CR84","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1188302","volume":"328","author":"D Huh","year":"2010","unstructured":"Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 2010;328(5986):1662\u20138. https:\/\/doi.org\/10.1126\/science.1188302. PubMed PMID: 20576885 ; PubMed Central PMCID: PMC8335790.","journal-title":"Science"},{"issue":"23","key":"3717_CR85","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1039\/c8lc00596f","volume":"18","author":"VS Shirure","year":"2018","unstructured":"Shirure VS, Bi Y, Curtis MB, Lezia A, Goedegebuure MM, Goedegebuure SP, et al. Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. Lab Chip. 2018;18(23):3687\u2013702. https:\/\/doi.org\/10.1039\/c8lc00596f. PubMed PMID: 30393802 ; PubMed Central PMCID: PMC10644986.","journal-title":"Lab Chip"},{"issue":"6","key":"3717_CR86","doi-asserted-by":"publisher","first-page":"e2412815","DOI":"10.1002\/adma.202412815","volume":"37","author":"Y Du","year":"2025","unstructured":"Du Y, Wang YR, Bao QY, Xu XX, Xu C, Wang S, et al. Personalized Vascularized Tumor Organoid-on-a-Chip for Tumor Metastasis and Therapeutic Targeting Assessment. Adv Mater. 2025;37(6):e2412815. https:\/\/doi.org\/10.1002\/adma.202412815. PubMed PMID: 39726096 .","journal-title":"Adv Mater"},{"issue":"1","key":"3717_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-024-01755-6","volume":"12","author":"JG Nicholson","year":"2024","unstructured":"Nicholson JG, Cirigliano S, Singhania R, Haywood C, Shahidi Dadras M, Yoshimura M, et al. Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growth. Acta Neuropathol Commun. 2024;12(1):46. https:\/\/doi.org\/10.1186\/s40478-024-01755-6. PubMed PMID: 38528608 ; PubMed Central PMCID: PMC10964514.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"3717_CR88","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41419-020-03379-9","volume":"12","author":"AM Kip","year":"2021","unstructured":"Kip AM, Soons Z, Mohren R, Duivenvoorden AAM, R\u00f6th AAJ, Cillero-Pastor B, et al. Proteomics analysis of human intestinal organoids during hypoxia and reoxygenation as a model to study ischemia-reperfusion injury. Cell Death Dis. 2021;12(1):95. https:\/\/doi.org\/10.1038\/s41419-020-03379-9. PubMed PMID: 33462215 ; PubMed Central PMCID: PMC7813872.","journal-title":"Cell Death Dis"},{"issue":"9","key":"3717_CR89","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1039\/d4lc01016g","volume":"25","author":"A Deipenbrock","year":"2025","unstructured":"Deipenbrock A, Wilmes BE, Sommermann T, Abdo N, Moustakas K, Raasch M, et al. Modelling of the multicellular tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC) on a fit-for-purpose biochip for preclinical drug discovery. Lab Chip. 2025;25(9):2168\u201381. https:\/\/doi.org\/10.1039\/d4lc01016g. PubMed PMID: 40018951 .","journal-title":"Lab Chip"},{"key":"3717_CR90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41698-020-0121-2","volume":"4","author":"P Datta","year":"2020","unstructured":"Datta P, Dey M, Ataie Z, Unutmaz D, Ozbolat IT. 3D bioprinting for reconstituting the cancer microenvironment. NPJ Precis Oncol. 2020;4:18. https:\/\/doi.org\/10.1038\/s41698-020-0121-2. PubMed PMID: 32793806 ; PubMed Central PMCID: PMC7385083.","journal-title":"NPJ Precis Oncol"},{"issue":"3","key":"3717_CR91","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","volume":"22","author":"B Artegiani","year":"2020","unstructured":"Artegiani B, Hendriks D, Beumer J, Kok R, Zheng X, Joore I, et al. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing. Nat Cell Biol. 2020;22(3):321\u201331. https:\/\/doi.org\/10.1038\/s41556-020-0472-5. PubMed PMID: 32123335 .","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3717_CR92","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41596-020-00411-2","volume":"16","author":"D Hendriks","year":"2021","unstructured":"Hendriks D, Artegiani B, Hu H, Chuva de Sousa Lopes S, Clevers H. Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver. Nat Protoc. 2021;16(1):182\u2013217. https:\/\/doi.org\/10.1038\/s41596-020-00411-2. PubMed PMID: 33247284 .","journal-title":"Nat Protoc"},{"issue":"7","key":"3717_CR93","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41576-020-0223-2","volume":"21","author":"DE Wagner","year":"2020","unstructured":"Wagner DE, Klein AM. Lineage tracing meets single-cell omics: opportunities and challenges. Nat Rev Genet. 2020;21(7):410\u201327. https:\/\/doi.org\/10.1038\/s41576-020-0223-2. PubMed PMID: 32235876 ; PubMed Central PMCID: PMC7307462.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"3717_CR94","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.devcel.2020.10.021","volume":"56","author":"S VanHorn","year":"2021","unstructured":"VanHorn S, Morris SA. Next-Generation Lineage Tracing and Fate Mapping to Interrogate Development. Dev Cell. 2021;56(1):7\u201321. https:\/\/doi.org\/10.1016\/j.devcel.2020.10.021. PubMed PMID: 33217333 .","journal-title":"Dev Cell"},{"issue":"1","key":"3717_CR95","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41592-021-01344-8","volume":"19","author":"Z He","year":"2022","unstructured":"He Z, Maynard A, Jain A, Gerber T, Petri R, Lin HC, et al. Lineage recording in human cerebral organoids. Nat Methods. 2022;19(1):90\u20139. https:\/\/doi.org\/10.1038\/s41592-021-01344-8. PubMed PMID: 34969984 ; PubMed Central PMCID: PMC8748197.","journal-title":"Nat Methods"},{"issue":"3","key":"3717_CR96","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/gutjnl-2021-325803","volume":"72","author":"MP de Andr\u00e9s","year":"2023","unstructured":"de Andr\u00e9s MP, Jackson RJ, Felipe I, Zagorac S, Pilarsky C, Schlitter AM, et al. GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma. Gut. 2023;72(3):535\u201348. https:\/\/doi.org\/10.1136\/gutjnl-2021-325803. PubMed PMID: 36109153 .","journal-title":"Gut"},{"issue":"18","key":"3717_CR97","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1158\/1078-0432.CCR-19-3724","volume":"26","author":"GM O\u2019Kane","year":"2020","unstructured":"O\u2019Kane GM, Gr\u00fcnwald BT, Jang GH, Masoomian M, Picardo S, Grant RC, et al. GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer. Clin Cancer Res. 2020;26(18):4901\u201310. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3724. PubMed PMID: 32156747 .","journal-title":"Clin Cancer Res"},{"issue":"52","key":"3717_CR98","doi-asserted-by":"publisher","first-page":"26580","DOI":"10.1073\/pnas.1911273116","volume":"116","author":"E Driehuis","year":"2019","unstructured":"Driehuis E, van Hoeck A, Moore K, Kolders S, Francies HE, Gulersonmez MC, et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc Natl Acad Sci U S A. 2019;116(52):26580\u201390. https:\/\/doi.org\/10.1073\/pnas.1911273116. PubMed PMID: 31818951 ; PubMed Central PMCID: PMC6936689.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03717-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:13:08Z","timestamp":1778206388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03717-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3717"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03717-3","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}